Featured Books
The Billion Dollar Battle; Merck v Glaxo Lynn, Mathew 1991
Profiles the two leading players in the drug market at the start of the 1990s contrasting their corporate cultures as reflections of their respective corporate leaderships. It was ultimately the development of the first effective drug treatment for stomach ulcers, Zantac, and it successful worldwide marketing into a billion-dollar revenue earner, that transformed Glaxo.
Keys: Glaxo, Wellcome, Pharmaceuticals, Drugs, Zantac, Merck, Girolami, Vagelos, GSK
|
More details and purchasing options |
Smith and Nephew in the Healthcare Industry Foreman-Peck, J. 1995
Originated as a chemist, distributing cod-liver oil. Moved into bandaging on the back of military contracts in early part of the century, then diversified into textile-ralted businesses before a period of innovation which produced elasticated bandage. Began international sales early on with an enduring legacy in the commonwealth. Now one of the largest orthopeadic companies in the world with a strong position in endoscopy and wound management.
Keys: Smith Nephew, Medical, Pharmaceuticals, Drugs, Dressings, Healthcare, Medicine, Hull
|
More details and purchasing options |
From Pills to Penicillin: The Beecham Story Lazell, H.G. 1975
Biographical account of a former Beecham Chairman. Begins with his earlier career at Macleans, and the period in which the leading brands (Eno, Macleans, and Brylcream) were brought together by Philip Hill. This was in an era where the marketing prowess of the group was to the fore. In the post-war period we see the development of scientific medicine, and the role of Beecham Research Laboratories which Lazell was keen to push forward. By the end of the 1950s, the company had developed over 200 new penicillins, among which a number of effective varieties were commercialised. The company has since merged with US company SmithKline which in turn has now merged with Glaxo-Wellcome
Keys: Beecham, Lazell, Maclean, GlaxoSmithKline, GSK, Drugs, Pharmaceuticals, Healthcare, Antibiotics, Penicillin, Penbritin, Worthing, Brands, Lucozade, Ribena, Horlicks, Brylcream
|
More details and purchasing options |
The Billion Dollar Molecule : One Company's Quest for the Perfect Drug Werth, Barry 1994
Exciting, fast-paced account of the race to design a drug and build a company. Drama switches rapidly from laboratory to board-room. The original goal of the company was the investigation of the structure and function of the immunosuppressant molecules Cyclosporin and newly-discovered FK-506, to enable the development of a new, safer, effective drug for use in facilitating organ transplants. Commercial pressure and serendipty result in the objectives broadening out in the search for a blockbuster - leading eventually to work with potential anti-viral treatments for AIDS.
Keys: Vertex, Biochemistry, Joshua Berger, Drug Design, immunosupressant, FKBP, Fujisawa, FK-506, Glaxo, Merck, Aldrich, AIDS, Chugai, Cyclosporine, Matt Harding, Mark Murcko, John Thomspn
|
More details and purchasing options |
Previous Featured Books | More Featured Books |
